SCHEMBL7681530

SCHEMBL7681530

CCCCOc1c(C)cccc1C(=O)N1CCN(Cc2cnc(C)n2Cc2ccc(C#N)c(Oc3cccnc3C)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FNTA P49354 8/20 0.43
FNTB P49356 8/20 0.43
PGGT1B P53609 8/20 0.43
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
POLB P06746 1/20 0.35
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
TLR7 Q9NYK1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7688301 0.93 ALDH1A1 (0.45) FNTAFNTBPGGT1BALDH1A1KDM4E
SCHEMBL7681543 0.92 FNTA (0.47) FNTAFNTBPGGT1BALDH1A1KDM4E
SCHEMBL7687530 0.90 FNTA (0.44) FNTAFNTBPGGT1BALDH1A1KDM4E
SCHEMBL7683740 0.89 FNTA (0.44) FNTAFNTBPGGT1BALDH1A1KDM4E
SCHEMBL7690628 0.88 FNTA (0.42) FNTAFNTBPGGT1BALDH1A1KDM4E
SCHEMBL7621675 0.88 FNTA (0.46) FNTAFNTBPGGT1BALDH1A1KDM4E
SCHEMBL7690190 0.86 FNTA (0.48) FNTAFNTBPGGT1BALDH1A1KDM4E
SCHEMBL7681980 0.86 FNTA (0.48) FNTAFNTBPGGT1BALDH1A1KDM4E
SCHEMBL7687366 0.84 FNTA (0.45) FNTAFNTBPGGT1BALDH1A1KDM4E
SCHEMBL7689564 0.83 FNTA (0.44) FNTAFNTBPGGT1BALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020052363-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-05-02 US claimed
US-20020052363-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052363-A1 Inhibitors of prenyl-protein transferase FNTA, FNTB, PTAR1 FNTA 1/4885FNTB 2/4885PGGT1B 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.